161 related articles for article (PubMed ID: 20420692)
1. Gene expression profiles help identify the tissue of origin for metastatic brain cancers.
Wu AH; Drees JC; Wang H; VandenBerg SR; Lal A; Henner WD; Pillai R
Diagn Pathol; 2010 Apr; 5():26. PubMed ID: 20420692
[TBL] [Abstract][Full Text] [Related]
2. A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors.
Handorf CR; Kulkarni A; Grenert JP; Weiss LM; Rogers WM; Kim OS; Monzon FA; Halks-Miller M; Anderson GG; Walker MG; Pillai R; Henner WD
Am J Surg Pathol; 2013 Jul; 37(7):1067-75. PubMed ID: 23648464
[TBL] [Abstract][Full Text] [Related]
3. Clinical verification of the performance of the pathwork tissue of origin test: utility and limitations.
Dumur CI; Fuller CE; Blevins TL; Schaum JC; Wilkinson DS; Garrett CT; Powers CN
Am J Clin Pathol; 2011 Dec; 136(6):924-33. PubMed ID: 22095379
[TBL] [Abstract][Full Text] [Related]
4. Accurate classification of metastatic brain tumors using a novel microRNA-based test.
Mueller WC; Spector Y; Edmonston TB; St Cyr B; Jaeger D; Lass U; Aharonov R; Rosenwald S; Chajut A
Oncologist; 2011; 16(2):165-74. PubMed ID: 21273512
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer transcriptome analysis reveals a gene expression signature for the identification of tumor tissue origin.
Xu Q; Chen J; Ni S; Tan C; Xu M; Dong L; Yuan L; Wang Q; Du X
Mod Pathol; 2016 Jun; 29(6):546-56. PubMed ID: 26990976
[TBL] [Abstract][Full Text] [Related]
6. Identification of tissue of origin in body fluid specimens using a gene expression microarray assay.
Stancel GA; Coffey D; Alvarez K; Halks-Miller M; Lal A; Mody D; Koen T; Fairley T; Monzon FA
Cancer Cytopathol; 2012 Feb; 120(1):62-70. PubMed ID: 21717591
[TBL] [Abstract][Full Text] [Related]
7. Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens.
Pillai R; Deeter R; Rigl CT; Nystrom JS; Miller MH; Buturovic L; Henner WD
J Mol Diagn; 2011 Jan; 13(1):48-56. PubMed ID: 21227394
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of uncertain primary tumors with the Pathwork tissue-of-origin test.
Monzon FA; Dumur CI
Expert Rev Mol Diagn; 2010 Jan; 10(1):17-25. PubMed ID: 20014919
[TBL] [Abstract][Full Text] [Related]
9. An integrated tool for determining the primary origin site of metastatic tumours.
Santos MTD; Souza BF; Cárcano FM; Vidal RO; Scapulatempo-Neto C; Viana CR; Carvalho AL
J Clin Pathol; 2018 Jul; 71(7):584-593. PubMed ID: 29248889
[TBL] [Abstract][Full Text] [Related]
10. Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression test.
Monzon FA; Medeiros F; Lyons-Weiler M; Henner WD
Diagn Pathol; 2010 Jan; 5():3. PubMed ID: 20205775
[TBL] [Abstract][Full Text] [Related]
11. Comparison of histopathology to gene expression profiling for the diagnosis of metastatic cancer.
Kulkarni A; Pillai R; Ezekiel AM; Henner WD; Handorf CR
Diagn Pathol; 2012 Aug; 7():110. PubMed ID: 22909314
[TBL] [Abstract][Full Text] [Related]
12. A 92-gene cancer classifier predicts the site of origin for neuroendocrine tumors.
Kerr SE; Schnabel CA; Sullivan PS; Zhang Y; Huang VJ; Erlander MG; Brachtel EF; Dry SM
Mod Pathol; 2014 Jan; 27(1):44-54. PubMed ID: 23846576
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
Laprovitera N; Riefolo M; Porcellini E; Durante G; Garajova I; Vasuri F; Aigelsreiter A; Dandachi N; Benvenuto G; Agostinis F; Sabbioni S; Berindan Neagoe I; Romualdi C; Ardizzoni A; Trerè D; Pichler M; D'Errico A; Ferracin M
Mol Oncol; 2021 Oct; 15(10):2732-2751. PubMed ID: 34075699
[TBL] [Abstract][Full Text] [Related]
14. Gene expression microarray-based assay to determine tumor site of origin in a series of metastatic tumors to the ovary and peritoneal carcinomatosis of suspected gynecologic origin.
Azueta A; Maiques O; Velasco A; Santacana M; Pallares J; Novell A; Llombart-Cussac A; Gonzalez-Tallada X; Mozos A; Prat J; Pillai R; Mata M; Matias-Guiu X
Hum Pathol; 2013 Jan; 44(1):20-8. PubMed ID: 22939961
[TBL] [Abstract][Full Text] [Related]
15. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary.
Shen Y; Chu Q; Yin X; He Y; Bai P; Wang Y; Fang W; Timko MP; Fan L; Jiang W
Brief Bioinform; 2021 Mar; 22(2):2106-2118. PubMed ID: 32266390
[TBL] [Abstract][Full Text] [Related]
16. Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute.
Hainsworth JD; Rubin MS; Spigel DR; Boccia RV; Raby S; Quinn R; Greco FA
J Clin Oncol; 2013 Jan; 31(2):217-23. PubMed ID: 23032625
[TBL] [Abstract][Full Text] [Related]
17. Overview of various techniques/platforms with critical evaluation of each.
Agwa E; Ma PC
Curr Treat Options Oncol; 2013 Dec; 14(4):623-33. PubMed ID: 24243164
[TBL] [Abstract][Full Text] [Related]
18. Efficient identification of miRNAs for classification of tumor origin.
Søkilde R; Vincent M; Møller AK; Hansen A; Høiby PE; Blondal T; Nielsen BS; Daugaard G; Møller S; Litman T
J Mol Diagn; 2014 Jan; 16(1):106-15. PubMed ID: 24211363
[TBL] [Abstract][Full Text] [Related]
19. Implementation of a novel microarray-based diagnostic test for cancer of unknown primary.
van Laar RK; Ma XJ; de Jong D; Wehkamp D; Floore AN; Warmoes MO; Simon I; Wang W; Erlander M; van't Veer LJ; Glas AM
Int J Cancer; 2009 Sep; 125(6):1390-7. PubMed ID: 19536816
[TBL] [Abstract][Full Text] [Related]
20. 90-gene signature assay for tissue origin diagnosis of brain metastases.
Zheng Y; Ding Y; Wang Q; Sun Y; Teng X; Gao Q; Zhong W; Lou X; Xiao C; Chen C; Xu Q; Xu N
J Transl Med; 2019 Oct; 17(1):331. PubMed ID: 31570099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
